ArticleJournal of molecular and cellular cardiology2023

RyR2-stabilization therapy with dantrolene against left ventricular remodeling and lethal arrhythmia in heart failure.

Shigeki Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.